It's Giving Tuesday! Double your impact and donate today.
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: April 20, 2020
The US Food and Drug Administration (FDA) approved Jelmyto (mitomycin gel) for a type of urothelial cancer, which is a cancer of the lining of the urinary system.
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
Published on: April 16, 2019
The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
